Abivax Capital Expenditures (CapEx) Growth & History (ABVX)

Abivax's capital expenditures (capex) was €142,000 for fiscal 2025.

View full Abivax company overview

Abivax annual capital expenditures (capex) history

Abivax annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20252025-12-31€142,000−€498,000−77.81%
20242024-12-31€640,000€375,000+141.51%
20232023-12-31€265,000−€23,000−7.99%
20222022-12-31€288,000€241,000+512.77%
20212021-12-31€47,000

Abivax capital expenditures (capex) trends

Between the periods ended 2021-12-31 and 2025-12-31, Abivax's capital expenditures (capex) increased from €47,000 to €142,000, a change of €95,000. The latest reported quarter, Q1 2026, shows €54,000.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Abivax source filings ↗

Community posts

It’s quiet here.

No posts about ABVX yet. Start the conversation.

Write the first post